CBOE Exec Granted 1,066 RSUs as Part of Compensation Package
Cboe Global Markets, Inc.
Subscribe to track CBOE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
CBOE Exec Granted 1,066 RSUs as Part of Compensation Package
Company: Cboe Global Markets, Inc. (CBOE) Form: 4 | Filed: 2025-10-22 Significance: Low
Insider: Hocking Robert A Title: EVP, Global Head of Derivs. | Relationship: Officer
Transaction: • Type: Grant • Shares: 1,066 Restricted Stock Units • Price: $0.00 • Value: $0 • Owned After: 1,066
Key Insight: This is a routine grant of Restricted Stock Units (RSUs) to an executive, representing a negligible 0.001% of total shares outstanding. The transaction has no immediate market value.
Market Context: The grant is part of a standard executive compensation plan and does not signal a new insider opinion on the company's valuation. The RSUs vest over a three-year period starting in 2026.
Comprehensive Analysis
SEC Filing Analysis: Cboe Global Markets, Inc. (CBOE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive at Cboe Global Markets received a routine grant of 1,066 Restricted Stock Units (RSUs) as part of their compensation, with no immediate market value or significant impact on share structure.
- Market Impact: Neutral. This type of grant is a standard practice for executive compensation and is not expected to influence the stock price.
Company Information
| Field | Value |
|---|---|
| Company | Cboe Global Markets, Inc. |
| Ticker Symbol | CBOE |
| CIK | 0001374310 |
| Industry | SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES |
Insider Information
| Field | Value |
|---|---|
| Name | Hocking Robert A |
| CIK | 0002091082 |
| Title/Position | EVP, Global Head of Derivs. |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-20 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 1,066 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 1,066 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 1,066 |
| % of Shares Outstanding | 0.001% |
| Post-Transaction Ownership | 1,066 shares (0.001% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $24.80 billion, this $0 value transaction is immaterial.
- Ownership Concentration: The insider's post-transaction holding of 1,066 shares represents a negligible fraction (0.001%) of the total shares outstanding.
- Dilution Impact: The potential future conversion of these 1,066 RSUs into common stock would cause a minimal dilution of approximately 0.001%, which is insignificant for existing shareholders.
- Transaction Significance: The transaction's size relative to both market cap (0%) and shares outstanding (0.001%) is well below the thresholds for even moderate significance, confirming its status as a routine administrative event.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants are a common form of non-cash compensation and do not reflect an insider's discretionary investment decision. The market typically does not react to such filings.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is non-market and will not affect trading volume.
- Sentiment Indicator: Neutral. This filing provides no new information to alter market sentiment towards CBOE.
Investment Insights
Positive Market Indicators
- N/A. This filing does not present positive market indicators.
Risk Factors
- N/A. This filing does not present any new risk factors.
Key Takeaways
- Routine Compensation: The grant is a standard part of executive compensation and not a market-moving event.
- Negligible Dilution: The potential dilution from these RSUs is insignificant, representing only 0.001% of shares outstanding.
- No Insider Signal: As a non-discretionary award with a $0 price, this transaction does not provide any insight into the executive's view of the company's future performance.
Additional Context
Transaction Notes
- Vesting Schedule: The filing's footnotes indicate the RSUs vest in three equal annual installments beginning on February 19, 2026, meaning the shares are not accessible to the insider for a considerable time.
- Contingent Right: Each RSU represents a contingent right to receive one share of common stock upon vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
